Pretreatment platelet-to-lymphocyte ratio (PLR) as a predictor of response to first-line platinum-based chemotherapy and prognosis for patients with non-small cell lung cancer

BACKGROUND: Previous studies showed the platelet-to-lymphocyte ratio (PLR) was associated with the prognosis of many tumors. However, to our knowledge, no study has explained the role of PLR in predicting response to first-line chemotherapy and prognosis for patients with non-small cell lung cancer...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Liu, Hongbing, Wu, Ying, Wang, Zhaofeng, Yao, Yanwen, Chen, Fangfang, Zhang, He, Wang, Yunfen, Song, Yong
Format: Artigo
Idioma:Inglês
Publicat: Pioneer Bioscience Publishing Company 2013
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3886705/
https://ncbi.nlm.nih.gov/pubmed/24409356
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2013.12.34
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars